Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,479 INR | +0.96% | -3.92% | +17.43% |
May. 27 | Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research | RE |
May. 25 | Sun Pharma to Pursue M&A | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.43% | 42.25B | |
+15.37% | 21.27B | |
+19.73% | 15.23B | |
+19.84% | 14.36B | |
+51.59% | 12.74B | |
-0.05% | 6.79B | |
-12.40% | 6.61B | |
-8.87% | 5.73B | |
+14.28% | 5.66B | |
+7.31% | 4.8B |
- Stock Market
- Equities
- SUNPHARMA Stock
- News Sun Pharmaceutical Industries Ltd.
- Sun Pharma Unit and SPARC Sign Licensing Deal for Neonatal Seizure Drug in US